Article
Can luteolin be a therapeutic molecule for both colon cancer and diabetes?
24 Oct 2018
Abstract excerpt
Diabetes and colon cancer are the leading cause of mortality worldwide. According to World Health Organization, the number of patients with diabetes and cancer is going to be elevated by 50% in 2020. However, several flavonoids have been known to be useful in reducing the chance of cancer/diabetes but the hunt of a single biomolecule that can act as therapeutic and preventive molecules for future epidemic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
